Smallpox- therapeutics under development, Growth Trends, Pipeline Review 2019

Albany, US, 2019-Sep-30 — /EPR Network/ —This research report titled “Smallpox-Pipeline Review, H2 2019” has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Smallpox during the period 2019 and 2025. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities in order to enlighten the readers about the actual scenario prevailing in the Smallpox

Get Sample Copy at

Smallpox – Pipeline Review, H2 2019


Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Smallpox – Pipeline Review, H2 2019, provides an overview of the Smallpox (Infectious Disease) pipeline landscape.

Smallpox is an acute contagious infection caused by the Variola virus. Symptoms include fever, malaise, headache, prostration, severe back pain, abdominal pain and vomiting. This is followed by the development of rashes on the face, hands, forearms and the trunk. Lesions develop in the mucous membranes of the nose and mouth which ulcerate, releasing large amounts of virus into the mouth and throat. Treatment includes medications such as antiviral and lifestyle modification.

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Smallpox – Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Smallpox (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Smallpox (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Smallpox and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Preclinical and Discovery stages are 1, 1, 6 and 3 respectively.

Smallpox (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.


– The pipeline guide provides a snapshot of the global therapeutic landscape of Smallpox (Infectious Disease).
– The pipeline guide reviews pipeline therapeutics for Smallpox (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Smallpox (Infectious Disease) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Smallpox (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Smallpox (Infectious Disease)

Browse Complete Report at

Table of Contents
List of Tables
List of Figures
Global Markets Direct Report Coverage
Smallpox – Overview
Smallpox – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Smallpox – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Smallpox – Companies Involved in Therapeutics Development
Bavarian Nordic A/S
BioFactura Inc
Chimerix Inc
CJ HealthCare Corp
EpiVax Inc
SIGA Technologies Inc
Tonix Pharmaceuticals Holding Corp
Smallpox – Drug Profiles
brincidofovir – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CEL-1000 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CJ-40011 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclonal Antibodies for Smallpox and Vaccinia Infections – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclonal Antibody for Smallpox – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PL-801 – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
smallpox [ankara] vaccine – Drug Profile
Product Description
Mechanism Of Action
R&D Progress
smallpox vaccine – Drug Profile
Product Description
Mechanism Of Action

Make an Enquiry about This Report

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like Pharmaceuticals market research   and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,

Albany, NY 12207,

United States

Toll Free: 800-998-4852 (US-Canada)



Read Industry News at:

Matched content

Editor’s pick

Express Press Release Distribution